Adverse event profiles of immune checkpoint inhibitor-based strategies for metastatic prostate cancer: a systematic review and network meta-analysis.
Background Immune checkpoint inhibitor (ICI)-based combination strategies are increasingly evaluated in metastatic prostate cancer (mPCa), but their comparative safety profiles remain uncertain. We conducted a systematic review and network meta-analysis (NMA) to compare adverse event (AE) profiles of ICI-based strategi...